Usefulness of cardiometabolic index for the estimation of ischemic stroke risk among general population in rural China

References

• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480687 adults. Circulation. 2017;135:759–771.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang D, Wong KS, et al. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42:3651–3654.
   PubMed Web of Science ®Google Scholar
• Wang J, An Z, Li B, et al. Increasing stroke incidence and prevalence of risk factors in a low-income Chinese population. Neurology. 2015;84:374–381.
   PubMed Web of Science ®Google Scholar
• Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381:1987–2015.
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104:1108–1113.
   PubMed Web of Science ®Google Scholar
• Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829–1839.
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Sacks FM, Salvini S, et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373–381.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tuomilehto J, Jousilahti P, et al. Total and high-density lipoprotein cholesterol and stroke risk. Stroke. 2012;43:1768–1774.
   PubMed Web of Science ®Google Scholar
• Kurth T, Everett BM, Buring JE, et al. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007;68:556–562.
   PubMed Web of Science ®Google Scholar
• Pikula A, Beiser AS, Wang J, et al. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study. Neurology. 2015;84:472–479.
   PubMed Web of Science ®Google Scholar
• Amarenco P, Labreuche J, Touboul PJ. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis. 2008;196:489–496.
   PubMed Web of Science ®Google Scholar
• Bowman TS, Sesso HD, Ma J, et al. Cholesterol and the risk of ischemic stroke. Stroke. 2003;34:2930–2934.
   PubMed Web of Science ®Google Scholar
• Willey JZ, Xu Q, Boden-Albala B, et al. Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol. 2009;66:1400–1406.
   PubMedGoogle Scholar
• Woodward M, Barzi F, Feigin V, et al. Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. Eur Heart J. 2007;28:2653–2660.
   PubMed Web of Science ®Google Scholar
• Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34:623–631.
   PubMed Web of Science ®Google Scholar
• Bonaventure A, Kurth T, Pico F, et al. Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: the Three-City Study. Atherosclerosis. 2010;210:243–248.
   PubMed Web of Science ®Google Scholar
• Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97:1007–1009.
   PubMed Web of Science ®Google Scholar
• Salazar MR, Carbajal HA, Espeche WG, et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012;109:1749–1753.
   PubMed Web of Science ®Google Scholar
• Bittner V, Johnson BD, Zineh I, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J. 2009;157:548–555.
   PubMed Web of Science ®Google Scholar
• Barzi F, Patel A, Woodward M, et al. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol. 2005;15:405–413.
   PubMed Web of Science ®Google Scholar
• Turak O, Afsar B, Ozcan F, et al. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict new cardiovascular events in essential hypertensive patients. J Clin Hypertens. 2016;18:772–777.
   Web of Science ®Google Scholar
• Park JH, Lee J, Ovbiagele B. Nontraditional serum lipid variables and recurrent stroke risk. Stroke. 2014;45:3269–3274.
   PubMed Web of Science ®Google Scholar
• Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377:1085–1095.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640–1649.
   PubMed Web of Science ®Google Scholar
• Zhang X, Shu XO, Gao YT, et al. General and abdominal adiposity and risk of stroke in Chinese women. Stroke. 2009;40:1098–1104.
   PubMed Web of Science ®Google Scholar
• Winter Y, Pieper L, Klotsche J, et al. Obesity and abdominal fat markers in patients with a history of stroke and transient ischemic attacks. J Stroke Cerebrovasc Dis. 2016;25:1141–1147.
   PubMed Web of Science ®Google Scholar
• Winter Y, Rohrmann S, Linseisen J, et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke. 2008;39:3145–3151.
   PubMed Web of Science ®Google Scholar
• Bodenant M, Kuulasmaa K, Wagner A, et al. Measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. Stroke. 2011;42:2872–2877.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Campello A, Jimenez-Conde J, Ois A, et al. Sex-related differences in abdominal obesity impact on ischemic stroke risk. Eur J Neurol. 2017;24:397–403.
   PubMed Web of Science ®Google Scholar
• Ioachimescu AG, Brennan DM, Hoar BM, et al. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring, Md). 2010;18:1836–1844.
   PubMed Web of Science ®Google Scholar
• Tellechea ML, Aranguren F, Martinez-Larrad MT, et al. Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care. 2009;32:e85.
   PubMedGoogle Scholar
• Zhong C, Xia W, Zhong X, et al. Lipid accumulation product and hypertension related to stroke: a 9.2-year prospective study among mongolians in China. J Atheroscler Thromb. 2016;23:830–838.
   PubMed Web of Science ®Google Scholar
• Wakabayashi I, Daimon T. The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274–278.
   PubMed Web of Science ®Google Scholar
• Wakabayashi I. A U-shaped relationship between alcohol consumption and cardiometabolic index in middle-aged men. Lipids Health Dis. 2016;15:50.
   PubMed Web of Science ®Google Scholar
• Wakabayashi I, Sotoda Y, Hirooka S, et al. Association between cardiometabolic index and atherosclerotic progression in patients with peripheral arterial disease. Clin Chim Acta. 2015;446:231–236.
   PubMed Web of Science ®Google Scholar
• O’Neal WT, Efird JT, Nazarian S, et al. Peripheral arterial disease and risk of atrial fibrillation and stroke: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2014;3:e001270.
   PubMed Web of Science ®Google Scholar
• Khoury JC, Kleindorfer D, Alwell K, et al. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke. 2013;44:1500–1504.
   PubMed Web of Science ®Google Scholar
• Chen S, Guo X, Dong S, et al. Relationship between lifestyle factors and hyperhomocysteinemia in general Chinese population: a cross-sectional study. Postgrad Med. 2017;129:216–223.
   PubMed Web of Science ®Google Scholar
• Chen S, Guo X, Chen Y, et al. Prevalence of abnormal serum liver enzymes in patients with type 2 diabetes mellitus: a cross-sectional study from China. Postgrad Med. 2016;128:770–776.
   PubMed Web of Science ®Google Scholar
• Li Z, Bai Y, Guo X, et al. Alcohol consumption and cardiovascular diseases in rural China. Int J Cardiol. 2016;215:257–262.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Basevi V, Di Mario S, Morciano C, et al. Standards of medical care in diabetes--2011. Diabetes care 2011;34 Suppl 1:S11–S61.
   Google Scholar
• Lee JS, Chang PY, Zhang Y, et al. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by Glycemic dysregulation status: the strong heart study. Diabetes Care. 2017;40:529–537.
   PubMed Web of Science ®Google Scholar
• Kurth T, Gaziano JM, Rexrode KM, et al. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation. 2005;111:1992–1998.
   PubMed Web of Science ®Google Scholar
• Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26.
   PubMedGoogle Scholar
• Da Luz PL, Cesena FH, Favarato D, et al. Comparison of serum lipid values in patients with coronary artery disease at <50, 50 to 59, 60 to 69, and >70 years of age. Am J Cardiol. 2005;96:1640–1643.
   PubMed Web of Science ®Google Scholar
• Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275–286.
   PubMed Web of Science ®Google Scholar
• Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev. 2010;23:247–269.
   PubMed Web of Science ®Google Scholar
• Tohidi M, Mohebi R, Cheraghi L, et al. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study. Clin Biochem. 2013;46:716–721.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun Z, Zhang X, et al. Gender differences in blood lipids and the risk of ischemic stroke among the hypertensive adults in rural China. Neurol India. 2007;55:338–342.
   PubMed Web of Science ®Google Scholar
• Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001;4:499–502.
   PubMed Web of Science ®Google Scholar
• Katsiki N, Ntaios G, Vemmos K. Stroke, obesity and gender: a review of the literature. Maturitas. 2011;69:239–243.
   PubMed Web of Science ®Google Scholar
• Goh LG, Dhaliwal SS, Welborn TA, et al. Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study. BMJ Open. 2014;4:e004138.
   PubMed Web of Science ®Google Scholar
• Ho SC, Chen YM, Woo JL, et al. Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord. 2001;25:1689–1697.
   PubMed Web of Science ®Google Scholar
• Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8:453–463.
   PubMed Web of Science ®Google Scholar
• Razani B, Chakravarthy MV, Semenkovich CF. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am. 2008;37:603–621, viii.
   PubMed Web of Science ®Google Scholar
• Rundek T, Gardener H, Xu Q, et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol. 2010;67:1195–1200.
   PubMedGoogle Scholar
• Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–880.
   PubMed Web of Science ®Google Scholar
• Ridker PM. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation. 2002;105:2583–2585.
   PubMed Web of Science ®Google Scholar